These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7842137)

  • 1. Electrochemical studies of tirapazamine: generation of the one-electron reduction product.
    Tocher JH; Edwards DI
    Free Radic Res; 1994 Oct; 21(5):277-83. PubMed ID: 7842137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdialysis sampling with on-line microbore HPLC for the determination of tirapazamine and its reduced metabolites in rats.
    McLaughlin KJ; Faibushevich AA; Lunte CE
    Analyst; 2000 Jan; 125(1):105-10. PubMed ID: 10885067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrochemical properties as a function of pH for the benzotriazine di-N-oxides.
    Tocher JH; Virk NS; Edwards DI
    Free Radic Res Commun; 1990; 10(4-5):295-302. PubMed ID: 2289695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrochemical studies and DNA damaging effects of the benzotriazine-N-oxides.
    Tocher JH; Virk NS; Edwards DI
    Biochem Pharmacol; 1990 Feb; 39(4):781-6. PubMed ID: 2137694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective interaction of tirapazamine with DNA bases and DNA. A comparison of cyclic voltammetry and electrolysis techniques.
    Tocher JH
    Free Radic Res; 2001 Aug; 35(2):159-66. PubMed ID: 11697196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugs.
    Wardman P; Priyadarsini KI; Dennis MF; Everett SA; Naylor MA; Patel KB; Stratford IJ; Stratford MR; Tracy M
    Br J Cancer Suppl; 1996 Jul; 27():S70-4. PubMed ID: 8763850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of the cytotoxicity of the anticancer agent tirapazamine by benzotriazine N-oxides: the role of redox equilibria.
    Anderson RF; Shinde SS; Hay MP; Denny WA
    J Am Chem Soc; 2006 Jan; 128(1):245-9. PubMed ID: 16390153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of 2-deoxyribose by benzotriazinyl radicals of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides.
    Shinde SS; Anderson RF; Hay MP; Gamage SA; Denny WA
    J Am Chem Soc; 2004 Jun; 126(25):7865-74. PubMed ID: 15212534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-electrode amperometric detection for the determination of SR4233 and its metabolites with microbore liquid chromatography.
    Liang XZ; Palsmeier RK; Lunte CE
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):113-9. PubMed ID: 8833973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide antitumor agents to oxidizing species following their one-electron reduction.
    Anderson RF; Shinde SS; Hay MP; Gamage SA; Denny WA
    J Am Chem Soc; 2003 Jan; 125(3):748-56. PubMed ID: 12526674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-amino-1,2,4-benzotriazine 4-oxide: characterization of a new metabolite arising from bioreductive processing of the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).
    Fuchs T; Chowdhury G; Barnes CL; Gates KS
    J Org Chem; 2001 Jan; 66(1):107-14. PubMed ID: 11429885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaction of the hypoxia-selective antitumor agent tirapazamine with a C1'-radical in single-stranded and double-stranded DNA: the drug and its metabolites can serve as surrogates for molecular oxygen in radical-mediated DNA damage reactions.
    Hwang JT; Greenberg MM; Fuchs T; Gates KS
    Biochemistry; 1999 Oct; 38(43):14248-55. PubMed ID: 10571998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The one-electron reduction potential of 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine): a hypoxia-selective bioreductive drug.
    Priyadarsini KI; Tracy M; Wardman P
    Free Radic Res; 1996 Nov; 25(5):393-9. PubMed ID: 8902537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.
    Monge A; Palop JA; López de Ceráin A; Senador V; Martínez-Crespo FJ; Sainz Y; Narro S; García E; de Miguel C; González M
    J Med Chem; 1995 May; 38(10):1786-92. PubMed ID: 7752202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical properties governing the hypoxia-selective cytotoxicity of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides.
    Anderson RF; Shinde SS; Hay MP; Gamage SA; Denny WA
    Org Biomol Chem; 2005 Jun; 3(11):2167-74. PubMed ID: 15917906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward hypoxia-selective DNA-alkylating agents built by grafting nitrogen mustards onto the bioreductively activated, hypoxia-selective DNA-oxidizing agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).
    Johnson KM; Parsons ZD; Barnes CL; Gates KS
    J Org Chem; 2014 Aug; 79(16):7520-31. PubMed ID: 25029663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemical and photobiological studies of tirapazamine (SR 4233) and related quinoxaline 1,4-Di-N-oxide analogues.
    Inbaraj JJ; Motten AG; Chignell CF
    Chem Res Toxicol; 2003 Feb; 16(2):164-70. PubMed ID: 12588187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mass spectrometry study of tirapazamine and its metabolites. insights into the mechanism of metabolic transformations and the characterization of reaction intermediates.
    Zagorevskii D; Song M; Breneman C; Yuan Y; Fuchs T; Gates KS; Greenlief CM
    J Am Soc Mass Spectrom; 2003 Aug; 14(8):881-92. PubMed ID: 12892912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damaging effects and voltammetric studies on the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxide, SR4233, as a function of pH.
    Tocher JH; Virk NS; Edwards DI
    Biochem Pharmacol; 1990 Sep; 40(6):1405-10. PubMed ID: 2144963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spin trapping of radicals other than the *OH radical upon reduction of the anticancer agent tirapazamine by cytochrome P450 reductase.
    Shinde SS; Hay MP; Patterson AV; Denny WA; Anderson RF
    J Am Chem Soc; 2009 Oct; 131(40):14220-1. PubMed ID: 19772319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.